In 2018, cross-border M&A activities in life science and healthcare continued to scale up. Europe has become the next popular choice after the US for Chinese pharmaceutical companies to look for technological breakthroughs.
If you missed the China Focus@JPM Week, it is the perfect time to register and get ready for our next Event. China Focus@Europe Spring, to be held in Vienna on March 27, is going to bring together decision makers from biotechnology, pharmaceuticals and investment to promote collaboration efficiently.
Get €150 off with early bird pricing through Feb 25th.
Learn more info at：https://events.mybiogate.com/europespring/